Sharecafe

Prescient Therapeutics (ASX:PTX) – TechKnow Invest Roadshow, August 2023

Steven Yatomi Clarke - CEO and Managing Director - Prescient Therapeutics (ASX:PTX) is a clinical-stage biotech company developing personalised medicine approaches to cancer, including targeted and cellular therapies.

 

Steven Yatomi Clarke – CEO and Managing Director – Prescient Therapeutics (ASX:PTX) is a clinical-stage biotech company developing personalised medicine approaches to cancer, including targeted and cellular therapies.

Serving up fresh finance news, marker movers & expertise.
LinkedIn
Email
X

All Categories